select trial semaglutide ppt Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design STEP-HFpEF Trial

Safety, Tolerability, and Who Should Avoid Semaglutide Common semaglutide side effects include nausea, constipation, and vomitingtypically mild to moderate and dose-dependent

Wegovy contains the active ingredient semaglutide and is administered once weekly by subcutaneous injection, or injection under the skin

Starting low and escalating gradually produced fewer gastrointestinal side effects than starting directly at a higher dose, which is why the 2mg +2mg-every-4-weeks schedule became the standard escalation approach in the published data

The secondary efficacy endpoints included here are as follows: percent change in body weight at week 48

The 1mg starting dose feels like wasting time

The role of GLP-1 receptor agonists in type 2 diabetes: Mechanisms and clinical implications